Hepatitis C virus infection and type 1 and type 2 diabetes mellitus

Hepatitis C virus(HCV) infection and diabetes mellitus are two major public health problems that cause devastating health and financial burdens worldwide. Diabetes can be classified into two major types: type 1 diabetes mellitus(T1DM) and T2 DM. T2 DM is a common endocrine disorder that encompasses...

Full description

Saved in:
Bibliographic Details
Published in:World journal of diabetes 2014-10, Vol.5 (5), p.586-600
Main Authors: Antonelli, Alessandro, Ferrari, Silvia Martina, Giuggioli, Dilia, Di Domenicantonio, Andrea, Ruffilli, Ilaria, Corrado, Alda, Fabiani, Silvia, Marchi, Santino, Ferri, Clodoveo, Ferrannini, Ele, Fallahi, Poupak
Format: Article
Language:English
Subjects:
diabetes
Epidemiology
Hepatitis
infection
mellitus
Pathogenesis
Prevention
Topic Highlight
Treatment
Type
virus
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hepatitis C virus(HCV) infection and diabetes mellitus are two major public health problems that cause devastating health and financial burdens worldwide. Diabetes can be classified into two major types: type 1 diabetes mellitus(T1DM) and T2 DM. T2 DM is a common endocrine disorder that encompasses multifactorial mechanisms, and T1 DM is an immunologically mediated disease. Many epidemiological studies have shown an association between T2 DM and chronic hepatitis C(CHC) infection. The processes through which CHC is associated with T2 DM seem to involve direct viral effects, insulin resistance, proinflammatory cytokines, chemokines, and other immunemediated mechanisms. Few data have been reported on the association of CHC and T1 DM and reports on the potential association between T1 DM and acute HCV infection are even rarer. A small number of studies indicate that interferon-α therapy can stimulate pancreatic autoim-munity and in certain cases lead to the development of T1 DM. Diabetes and CHC have important interactions. Diabetic CHC patients have an increased risk of developing cirrhosis and hepatocellular carcinoma compared with nondiabetic CHC subjects. However, clinical trials on HCV-positive patients have reported improvements in glucose metabolism after antiviral treatment. Further studies are needed to improve prevention policies and to foster adequate and cost-effec-tive programmes for the surveillance and treatment of diabetic CHC patients.
ISSN:1948-9358
1948-9358
DOI:10.4239/wjd.v5.i5.586